These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 11316070
1. Combined FTY720/cyclosporine A treatment promotes graft survival and lowers the peripheral lymphocyte count in DA to lewis heart and skin transplantation models. Nikolova Z, Hof A, Baumlin Y, Hof RP. Transpl Immunol; 2001 Feb; 8(4):267-77. PubMed ID: 11316070 [Abstract] [Full Text] [Related]
2. The peripheral lymphocyte count predicts graft survival in DA to Lewis heterotopic heart transplantation treated with FTY720 and SDZ RAD. Nikolova Z, Hof A, Baumlin Y, Hof RP. Transpl Immunol; 2000 Jun; 8(2):115-24. PubMed ID: 11005317 [Abstract] [Full Text] [Related]
3. Combined FTY720/cyclosporine treatment promotes graft survival and lowers the peripheral lymphocyte count in a murine cardiac allotransplantation model. Nikolova Z, Hof A, Baumlin Y, Hof RP. Transplantation; 2001 Jul 15; 72(1):168-71. PubMed ID: 11468555 [Abstract] [Full Text] [Related]
4. Efficacy of SDZ RAD compared with CsA monotherapyand combined Rad/FTY720 treatment in a murine cardiac allotransplantation model. Nikolova Z, Hof A, Baumlin Y, Hof RP. Transpl Immunol; 2001 Oct 15; 9(1):43-9. PubMed ID: 11680571 [Abstract] [Full Text] [Related]
5. Rejection following donor or recipient preoperative treatment with FTY720 in rat small bowel transplantation. Sakagawa T, Kiyochi H, Honda K, Kobayashi N. Transpl Immunol; 2004 Nov 15; 13(3):161-8. PubMed ID: 15381198 [Abstract] [Full Text] [Related]
6. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E. Circulation; 2005 Jan 18; 111(2):222-9. PubMed ID: 15642767 [Abstract] [Full Text] [Related]
7. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus. Wang ME, Tejpal N, Qu X, Yu J, Okamoto M, Stepkowski SM, Kahan BD. Transplantation; 1998 Apr 15; 65(7):899-905. PubMed ID: 9565092 [Abstract] [Full Text] [Related]
8. Prophylaxis of acute renal allograft rejection using FTY720 in combination with subtherapeutic doses of cyclosporine. Troncoso P, Stepkowski SM, Wang ME, Qu X, Chueh SC, Clark J, Kahan BD. Transplantation; 1999 Jan 15; 67(1):145-51. PubMed ID: 9921811 [Abstract] [Full Text] [Related]
10. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function. Silva FR, Silva LB, Cury PM, Burdmann EA, Bueno V. Int Immunopharmacol; 2006 Dec 20; 6(13-14):1911-8. PubMed ID: 17161344 [Abstract] [Full Text] [Related]
11. Prevention of graft vessel disease by combined FTY720/cyclosporine. A treatment in a rat carotid artery transplantation model. Nikolova Z, Hof A, Rudin M, Baumlin Y, Kraus G, Hof RP. Transplantation; 2000 Jun 27; 69(12):2525-30. PubMed ID: 10910272 [Abstract] [Full Text] [Related]
12. Oral efficacy of the new immunomodulator FTY720 in cynomolgus monkey kidney allotransplantation, given alone or in combination with cyclosporine or RAD. Schuurman HJ, Menninger K, Audet M, Kunkler A, Maurer C, Vedrine C, Bernhard M, Gaschen L, Brinkmann V, Quesniaux V. Transplantation; 2002 Oct 15; 74(7):951-60. PubMed ID: 12394836 [Abstract] [Full Text] [Related]
13. Immunosuppressive activity of FTY720, sphingosine 1-phosphate receptor agonist: I. Prevention of allograft rejection in rats and dogs by FTY720 and FTY720-phosphate. Chiba K, Hoshino Y, Ohtsuki M, Kataoka H, Maeda Y, Matsuyuki H, Sugahara K, Kiuchi M, Hirose R, Adachi K. Transplant Proc; 2005 Oct 15; 37(1):102-6. PubMed ID: 15808561 [Abstract] [Full Text] [Related]
14. Prolongation of concordant xenograft survival by treatment with FTY720. Miyata Y, Ohdan H, Noriyuki T, Shintaku S, Shibata S, Yamamoto H, Fan XH, Fudaba Y, Yoshioka S, Asahara T, Fukuda Y, Dohi K. Transplant Proc; 1998 Dec 15; 30(8):4163-5. PubMed ID: 9865334 [No Abstract] [Full Text] [Related]
16. Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs. Furukawa H, Suzuki T, Jin MB, Yamashita K, Taniguchi M, Magata S, Ishikawa H, Ogata K, Masuko H, Shimamura T, Fukai M, Hayashi T, Fujita M, Nagashima K, Omura T, Kishida A, Todo S. Transplantation; 2000 Jan 27; 69(2):235-41. PubMed ID: 10670633 [Abstract] [Full Text] [Related]
17. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A. Koshiba T, Van Damme B, Rutgeerts O, Waer M, Pirenne J. Transplantation; 2003 Apr 15; 75(7):945-52. PubMed ID: 12698078 [Abstract] [Full Text] [Related]
18. FTY720, a new immunosuppressant, as rescue therapy in mouse cardiac transplantation. Wang MH, Milekhin V, Zhang H, Huang HZ. Acta Pharmacol Sin; 2003 Sep 15; 24(9):847-52. PubMed ID: 12956930 [Abstract] [Full Text] [Related]
19. The novel immunosuppressant FTY720 induces peripheral lymphodepletion of both T- and B-cells in cynomolgus monkeys when given alone, with Cyclosporine Neoral or with RAD. Quesniaux VF, Menninger K, Kunkler A, Vedrine C, Bernhard M, Hedinger R, Kraus G, Schuurman HJ. Transpl Immunol; 2000 Nov 15; 8(3):177-87. PubMed ID: 11147698 [Abstract] [Full Text] [Related]
20. Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720. Chueh SC, Tian L, Wang M, Wang ME, Stepkowski SM, Kahan BD. Transplantation; 1997 Nov 27; 64(10):1407-14. PubMed ID: 9392303 [Abstract] [Full Text] [Related] Page: [Next] [New Search]